Effect of midazolam on pharmacokinetics of alectinib in cancer patients.

Trial Profile

Effect of midazolam on pharmacokinetics of alectinib in cancer patients.

Completed
Phase of Trial: Phase I

Latest Information Update: 22 Apr 2016

At a glance

  • Drugs Alectinib (Primary) ; Midazolam
  • Indications Non-small cell lung cancer
  • Focus Pharmacokinetics
  • Most Recent Events

    • 22 Apr 2016 New trial record
    • 12 Mar 2016 Results from this trial and other two trial (CTP 237396, 238878) presented at the 117th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top